Literature DB >> 18929397

Haemostatic profile of full-term, healthy, small for gestational age neonates.

George Mitsiakos1, Georgia Papaioannou, Emmanouil Papadakis, Elias Chatziioannidis, Evaggelia Giougi, Paraskevi Karagianni, Joanna Evdoridou, Pavlos Malindretos, Miranda Athanasiou, Fani Athanassiadou, Nikolaos Nikolaidis.   

Abstract

BACKGROUND: Small for Gestational Age (SGA) neonates often appear with haemostatic alterations, principally due to hepatic dysfunction that results from chronic intrauterine hypoxia. Polycythaemia and thrombocytopenia are common findings in this neonatal population. STUDY
DESIGN: We performed a comparison of coagulation, natural inhibitors and fibrinolysis between SGA and Appropriate for Gestational Age (AGA) infants born full term [gestational age (G.A.) >37 weeks]. Study population consisted of 188 healthy newborns, 90 of whom were SGA (62 females and 28 males), while the rest were the control group (44 females and 54 males). Blood samples were obtained within 30 minutes following birth and before the administration of vitamin K. Investigation included: PT, INR, APTT, fibrinogen, coagulation factors II, V, VII, VIII, IX, X, XI, XII, vWillebrand factor, protein C and free protein S, antithrombin (AT), APCR, tPA and PAI-1. The independent t-test was used to compare the differences between the values of haemostatic parameters.
RESULTS: Statistical analysis revealed a significant prolongation in PT, INR, elevated levels of tPA (p<0.015, 0.01 and 0.002 respectively) and a decrease in the values of XII and free protein S (p<0.045 and 0.007 respectively) in SGA full term neonates. The two groups had similar demographic characteristics (except birth weight), without significant differences in the values of other haemostatic parameters.
CONCLUSIONS: Despite of statistically significant differences in PT, INR, values of tPA, XII and free protein S, levels of haemostatic factors range within laboratory references for healthy full term newborns. These findings were not accompanied with clinical manifestations of altered haemostasis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18929397     DOI: 10.1016/j.thromres.2008.08.008

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  6 in total

1.  Thromboelastometry: studying hemostatic profile in small for gestational age neonates-a pilot observational study.

Authors:  Rozeta Sokou; Aikaterini Konstantinidi; Charikleia Stefanaki; Andreas G Tsantes; Stavroula Parastatidou; Katerina Lampropoulou; George Katsaras; Evagelia Tavoulari; Nicoletta Iacovidou; Elias Kyriakou; Antonios Gounaris; Stefanos Bonovas; Argirios E Tsantes
Journal:  Eur J Pediatr       Date:  2019-02-01       Impact factor: 3.183

Review 2.  Developmental hemostasis in the neonatal period.

Authors:  Vicente Rey Y Formoso; Ricardo Barreto Mota; Henrique Soares
Journal:  World J Pediatr       Date:  2022-01-04       Impact factor: 2.764

3.  Hemostatic profile in healthy premature neonates; does birth weight affect the coagulation profile?

Authors:  Alireza Abdollahi; Sara Sheikhbahaei; Nima Hafezi-Nejad; Behnaz Mahdaviani
Journal:  J Clin Neonatol       Date:  2014-04

4.  Early-Onset Thrombocytopenia in Small-For-Gestational-Age Neonates: A Retrospective Cohort Study.

Authors:  S F Fustolo-Gunnink; R D Vlug; V E H J Smits-Wintjens; E J Heckman; A B Te Pas; K Fijnvandraat; E Lopriore
Journal:  PLoS One       Date:  2016-05-13       Impact factor: 3.240

Review 5.  The Vascular Endothelium and Coagulation: Homeostasis, Disease, and Treatment, with a Focus on the Von Willebrand Factor and Factors VIII and V.

Authors:  Juan A De Pablo-Moreno; Luis Javier Serrano; Luis Revuelta; María José Sánchez; Antonio Liras
Journal:  Int J Mol Sci       Date:  2022-07-27       Impact factor: 6.208

6.  Differential Contributions of Intrinsic and Extrinsic Pathways to Thrombin Generation in Adult, Maternal and Cord Plasma Samples.

Authors:  Nicklaus T Rice; Fania Szlam; Jeffrey D Varner; Peter S Bernstein; Arthur D Szlam; Kenichi A Tanaka
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.